UnitedHealth Group (UNH) and Amedisys (AMED) extended the deadline for closing their $3.3 billion merger agreement as the US Department of Justice scrutinizes the deal, a filing showed Friday.
Under a waiver agreement executed Thursday, the deadline is extended to 10 days after a final court decision is issued in the lawsuit filed by the Justice Department to block the proposed acquisition or on Dec. 31, 2025, whichever is earlier, the filing showed.
The new agreement includes a regulatory break fee of $275 million, which may go up to $325 million if the companies fail to divest certain assets to gain approval, according to the filing.
Amedisys' shares were up more than 3% in recent premarket activity and UnitedHealth shares were marginally advancing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。